The certification covers Bend’s manufacture of clinical pharmaceutical supplies for human consumption and testing of the supplies at the company’s GMP facilities. Bend Research CEO Rod Ray said,
The Form 10 Registration Statement includes the significant information about Mallinckrodt and the separation, which contains an overview of the businesses in which Mallinckrodt will operate and of
According to the company, from the €2.6m grant it will receive €215.000, which would be used in its ongoing three year project of determining the clinical value of
A humanised monoclonal antibody Epratuzuma binds to the CD22 glycoprotein on the surface of B cells and is a well-validated target for hematological cancers. Algeta executive vice president
The Dana-Farber Cancer Institute, the Massachusetts General Hospital, the University of North Carolina at Chapel Hill, and The University of Texas Southwestern Medical Center jointly own the patent
Biocompatible, non-toxic remoldable synthetic antimicrobial hydrogel was developed to break diseased biofilms and eliminate drug-resistant bacteria. The hydrogel containong over 90% of water can be applied on hospital
The 13C- and 15N-labeled phytochemicals and plant products can be used in food & beverage, nutraceutical, pharmaceutical, cosmeceutical and environmental sciences research as tracers and internal standards. ChromaDex
Hidrox is an ingredient derived from olive polyphenols and the only formulation of organic hydroxytyrosol developed to reduce inflammation. CreAgri founder and CEO Roberto Crea said, "We’ve had
The new patent provides protection for the company’s universal flu vaccine target, M2e, which is a viral peptide common in all flu strains. Augmenta founder, president and CSO
The multi-center Trial 290-005 is designed to assess MGCD290 in combination with fluconazole against only fluconazole in vulvovaginal candidiasis (VVC) patients. MethylGene president and chief executive officer Dr.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.